α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes

P. A. Gottlieb; A. K. Alkanani; A. W. Michels; E. C. Lewis; L. Shapiro; C. A. Dinarello; D. Zipris

doi:10.1089/dia.2015.1510

α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes

P. A. Gottlieb
, A. K. Alkanani
, A. W. Michels
, E. C. Lewis
, L. Shapiro
, C. A. Dinarello
, D. Zipris

Department of Clinical Biochemistry and Pharmacology

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Original language	English
Pages (from-to)	S86-S87
Journal	Diabetes Technology and Therapeutics
Volume	17
DOIs	https://doi.org/10.1089/dia.2015.1510
State	Published - 1 Feb 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Endocrinology
Medical Laboratory Technology

Access to Document

10.1089/dia.2015.1510

Cite this

Gottlieb, P. A., Alkanani, A. K., Michels, A. W., Lewis, E. C., Shapiro, L., Dinarello, C. A., & Zipris, D. (2015). α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes. Diabetes Technology and Therapeutics, 17, S86-S87. https://doi.org/10.1089/dia.2015.1510

@article{5024d7053e8a4c8bbe32736c3faa8c30,

title = "α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes",

author = "Gottlieb, \{P. A.\} and Alkanani, \{A. K.\} and Michels, \{A. W.\} and Lewis, \{E. C.\} and L. Shapiro and Dinarello, \{C. A.\} and D. Zipris",

year = "2015",

month = feb,

day = "1",

doi = "10.1089/dia.2015.1510",

language = "English",

volume = "17",

pages = "S86--S87",

journal = "Diabetes Technology and Therapeutics",

issn = "1520-9156",

publisher = "Mary Ann Liebert Inc.",

}

Gottlieb, PA, Alkanani, AK, Michels, AW, Lewis, EC, Shapiro, L, Dinarello, CA & Zipris, D 2015, 'α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes', Diabetes Technology and Therapeutics, vol. 17, pp. S86-S87. https://doi.org/10.1089/dia.2015.1510

α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes. / Gottlieb, P. A.; Alkanani, A. K.; Michels, A. W. et al.
In: Diabetes Technology and Therapeutics, Vol. 17, 01.02.2015, p. S86-S87.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes

AU - Gottlieb, P. A.

AU - Alkanani, A. K.

AU - Michels, A. W.

AU - Lewis, E. C.

AU - Shapiro, L.

AU - Dinarello, C. A.

AU - Zipris, D.

PY - 2015/2/1

Y1 - 2015/2/1

UR - https://www.scopus.com/pages/publications/84923112428

U2 - 10.1089/dia.2015.1510

DO - 10.1089/dia.2015.1510

M3 - Comment/debate

C2 - 25679434

AN - SCOPUS:84923112428

SN - 1520-9156

VL - 17

SP - S86-S87

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

ER -

Gottlieb PA, Alkanani AK, Michels AW, Lewis EC, Shapiro L, Dinarello CA et al. α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes. Diabetes Technology and Therapeutics. 2015 Feb 1;17:S86-S87. doi: 10.1089/dia.2015.1510

α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this